Catalyst Wire Dossier Catalyst Wire Dossier

GS-9620

vesatolimod · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GS-9620, covering 2013-08-13 to 2013-12-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection [Phase 1]

See pricing